GlassScriptPhysician profile
Derek T Kirby
NPI 1407260854
$6,172.46
in general payments reported to CMS, 2019-2025
13 companies · $3,632 in 2025
The $3,632 reported for 2025 was more than what 98% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $625 · 2024: $1,916 · 2025: $3,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,037 · Travel and Lodging: $1,988 · Education: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,037.43 |
| Travel and Lodging | $1,988.28 |
| Education | $1,146.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,604.59 | 2024-2025 | Prostar, Jeti Peripheral Catheter, Esprit |
| W. L. Gore & Associates, INC. | $1,994.55 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Propaten Vascular Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $792.20 | 2023-2025 | Endurant Iis, Heli-Fx Endoanchor System, Hawkone |
| Silk Road Medical, INC. | $303.74 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bolton Medical INC | $122.90 | 2024 | Treo Abdominal Stent-Graft System |
| Lemaitre Vascular, INC. | $106.30 | 2024 | Hydro Lemaitre Valvulotome |
| Baxter Healthcare | $56.35 | 2024 | Perclot |
| Amgen INC. | $45.84 | 2024 | Repatha |
| Endologix LLC | $44.79 | 2025 | Afx2 Bifurcated Endograft System |
| Angiodynamics, INC. | $39.34 | 2023 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $29.45 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $18.19 | 2024 | Farxiga |
| Cordis US Corp. | $14.22 | 2024 | Radial 360 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.